This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tour DaVita Raises $900,000 For Bridge Of Life—DaVita Medical Missions

DaVita®, a division of DaVita HealthCare Partners, Inc. (NYSE: DVA) and a leading provider of kidney care services announced that its annual charity bike ride, Tour DaVita®, raised $900,000 to support Bridge of Life—DaVita Medical Missions TM in 2012.

The proceeds from Tour DaVita will help fund nine medical missions taking place in 2013 where Bridge of Life volunteers will be able to install or repair 112 dialysis machines. Through these missions, Bridge of Life will bring dialysis treatment to more than 600 people in communities that otherwise would not have access to this life-sustaining care.

“Tour DaVita participants collectively rode 70,000 miles, which means that for every four miles a rider completed Bridge of Life can provide a dialysis treatment to someone at one of our partnering clinics – someone’s loved one will receive a second chance at life,” said Lori Vaclavik, executive director for Bridge of Life—DaVita Medical Missions. “We are proud of all the riders and sponsors who made this gift possible. Because of them, people will live.”

More than 470 participants each pedaled approximately 250 miles over the course of three days in Iowa Sept. 16-18. The ride kicked off in scenic Wilder Park in Allison, Iowa, continuing on through the rolling hills of the American Heartland – all in the effort to raise awareness and funds in the fight against CKD.

Since it started in 2007, Tour DaVita has helped raise nearly $5 million in the fight against kidney disease. Participants have collectively ridden 420,000 miles over the years, challenging themselves and their fellow riders to go as far as possible.

DaVita thanks the sponsors who made this gift of life possible, including ASD Healthcare, Cigna, Baxter, NxStage, Office Depot, Golden Construction, Henry Schein, Promotional Images, KPMG, Pentec Health, and Tata Consultancy Services.

Life-saving dialysis is not available in most of the developing world. Currently there are 112 countries that do not have resources for dialysis or kidney transplants, which directly results in the death of more than one million people a year from kidney failure. The Centers for Disease Control and Prevention recognize CKD as a major public health problem that not only reduces the quality and length of life, but is also expensive to treat.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs